105 results
8-K
EX-10.1
NKGN
NKGen Biotech Inc
13 May 24
Entry into a Material Definitive Agreement
8:05am
) of the 1934 Act and Regulation 13D-G under the 1934 Act.
Nature of Agreement; No Other Amendments. The parties hereby acknowledge and agree
8-K
EX-10.5
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
obligation under this Note, the Borrower shall not, without the Holder’s written consent, (a) change the nature of its business; (b) sell, divest, change … , it is expressly agreed and provided that the total liability of the Company under this Note for payments which under the applicable law are in the nature
8-K
EX-10.3
v52ay3upd8 w6mxdj53w
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
i32483
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.6
0ip338vt5rf377xup
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
m6cqa7d
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
ggy086ti1cr5yh37g
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
6kel5n1
29 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
nkpp1
29 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
ntqeam
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.1
k1tf25f7 xiqujxrvj
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.3
0s9polgc
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.3
r4o2lb55
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm